AzTrials
AzTrials

Impingement SyndromeNCT05919121

Effect Of Hydrocortisone Phonophoresis Versus Iontophoresis In Patients With Subacromial Impingement Syndrome

A study testing Therapeutic exercise, hydrocortisone phonophoresis and hydrocortisone iontophoresis in people with Impingement Syndrome and Subacromial Impingement Syndrome, run by Horus University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study will be to compare the efficacy of adding hydrocortisone phonophoresis or iontophoresis on pain, function, range of motion and shoulder external rotation isometric strength in patients with subacromial impingement syndrome. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
What is being tested?
Therapeutic exercise, hydrocortisone phonophoresis and hydrocortisone iontophoresis
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
1 May 2023to 15 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • All patients were diagnosed as unilateral SIS with stage II Neer classification > 3 months.
  • Positive impingement sign (Neer's test or Hawkins-Kennedy test), / painful arc during active arm elevation, pain or weakness with resisted isometric external rotation or resisted scapular plane abduction with the humeral internal rotation (empty can test)
  • The age of patients ranged from 18 - 60 years old.
  • Both genders will be involved.
  • Shoulder pain scores more than 5 on a numeric rate scale for pain of 0- 10.
  • Failure to respond to conservative NSAID.

Who cannot join

  • Frozen shoulders.
  • Arthritis of the shoulder.
  • Shoulder instability.
  • Pregnant women.
  • A pacemaker.
  • Previous shoulder surgery.
Show all 15Show fewer
  • History of dislocation of the shoulder.
  • Internal metallic fixation.
  • Malignancy.
  • Previous corticosteroid injection.
  • Rheumatoid arthritis
  • Partial or Full thickness tear of the rotator cuff.
  • Cervical radiculopathy.
  • Physiotherapeutic shoulder treatment within the last 3 months.
  • The patients will randomly be assigned into 3 equal groups, 20 patients for each group.

Trial locations and contacts

1 site in 1 country.

Egypt1 site, 1 recruiting
  • Outpatient clinic faculty of physical therapy, horus university, egypt

    Damietta

    Mohsen Ibrahim, +201001407064, mabouelsoud@horus.edu.eg

    Recruiting

Other trials in Egypt

About this study

The purpose of this study will be to compare the efficacy of adding hydrocortisone phonophoresis or iontophoresis on pain, function, range of motion and shoulder external rotation isometric strength in patients with subacromial impingement syndrome.

Read the detailed description

Routine physiotherapy has been advocated was an effective treatment for SIS. However, there is lack of best exercise treatment and lots of studies are under consideration. According to published data focused on management of shoulder pain, it looks like that therapeutic exercise is not sufficient to treat SIS and it is compulsory to combine with other remedies to get the best results

Being tested
Therapeutic exercise, hydrocortisone phonophoresis, hydrocortisone iontophoresis
Medical subject headings
Shoulder Impingement Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Therapeutic exerciseOther

    1. Stretching exercise of posterior shoulder capsule
    2. Strengthening exercises: consists of 6 strengthening exercises all of which have been recommended as essential for any shoulder rehabilitation program.
    3. The remaining 2 exercises are the seated press-up and the elbow push up. Both will be performed to fatigue or for a maximum of 25 repetitions. The quality of all repetitions of each exercise will continuously monitored by the investigator of the study
  • hydrocortisone phonophoresisOther

    In this study, the effective area of radiation (ERA) in the mode continuous (100 percent) is 5 cm2, in 1 MHz and 0.7 W/cm2, with four ERA treated areas. Therapy lasted five minutes (three minutes in the insertion of the supraspinatus and 37 two minutes in the infraspinatus insertion) three times weekly over 6 weeks in addition to therapeutic exercises

  • hydrocortisone iontophoresisOther

    A direct current electrical stimulation unit will be used to apply iontophoresis. The unit has two electrodes; one electrode is for the negative current, and one is for the positive current. The Active (Negative) electrode will be placed on the anterolateral aspect of the shoulder joint. The passive electrode: will be placed on the upper arm region. Intensity of the current: Between the range of 3-5 mA at the point of sensation of patient was set. Treatment duration: Calculated accordingly with intensity of current. Method of application: hydrocortisone gel 10% will be administered by applying on the active rubber electrode for each session three times weekly over 6 weeks in addition to therapeutic exercises.

Study groups in NCT05919121
Study groupRoleWhat they receive
Therapeutic exercise groupActive comparatorTherapeutic exercise group, group A.
Receives: Other: Therapeutic exercise
hydrocortisone phonophoresis groupExperimentalThis group (B) will receive the same exercise program in addition to hydrocortisone phonophoresis. Patients will receive topical medium phonophoresis of 10% hydrocortisone gel.
Receives: Other: Therapeutic exercise; Other: hydrocortisone phonophoresis
hydrocortisone iontophoresis groupExperimentalThis group (C) will receive the same exercise program in addition to hydrocortisone iontophoresis.
Receives: Other: Therapeutic exercise; Other: hydrocortisone iontophoresis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessing the change in isometric shoulder strength

    A handheld Lafayette dynamometer will be used to evaluate the peak shoulder External Rotation muscles isometric strength

    Measured: at baseline and after 6 weeks of intervention

  2. Assessing the change in Shoulder Pain and Disability

    By using Shoulder Pain and Disability Index (SPADI). SPADI has been found to be the quickest (within five minutes) and easiest to complete, as well as being more responsive to change. The SPADI is considered to be, by comparison, one of the most useful instruments about the shoulder joint, and has been tested in various clinical settings. The SPADI is a 13-item shoulder function index on the ability of responders to carry out basic activities of daily living. Each item is scored by a numeric rating scale that ranges from 0 (no pain/no difficulty) to 10 (worst pain imaginable/so difficult it required help).

    Measured: at baseline and after 6 weeks of intervention

  3. Assessing the change in shoulder Range Of Motion

    In this study shoulder ROM will be measured by using Electrogoniometer (flexion, abduction and internal rotation ranges will be measured in degrees), which eliminates the need to manually score each measurement.

    Measured: at baseline and after 6 weeks of intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jun 2023
  2. Study start1 May 2023
  3. Primary completion15 Aug 2023 (estimated)
  4. Study completion15 Sep 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05919121
Sponsor's protocol ID
MOHSEN_IBRAHIM_phd
Status last verified
Jun 2023
First submitted
14 Jun 2023
Last updated
26 Jun 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Therapeutic exercise, hydrocortisone phonophoresis and hydrocortisone iontophoresis in people with Impingement Syndrome and Subacromial Impingement Syndrome, run by Horus University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mohsen Ibrahim (+201001407064, mabouelsoud@horus.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessing the change in isometric shoulder strength (time frame: at baseline and after 6 weeks of intervention). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in